8/19/2019 Presentation of Beximco Pharmaceuticals

1/22

 

PresentationPresentation

ononAnalysis ofAnalysis of

Dividend policy & Capital structureDividend policy & Capital structure

8/19/2019 Presentation of Beximco Pharmaceuticals

2/22

8/19/2019 Presentation of Beximco Pharmaceuticals

3/22

 

Overview of company• Beximco Parma is a leading edge parmaceuticalcompany based in Da!a" Banglades#

• Beximco Parma acclaimed for its outstanding

product $uality" world%class manufacturingfacilities" product development capabilities andoutstanding professional services#

•  Beximco Parma is also te largest exporter ofparmaceutical products from Banglades andreceived ational 'xport (ropy )*old+" teigest national accolade for export" for recordtree times#

8/19/2019 Presentation of Beximco Pharmaceuticals

4/22

 

Overview of company• ,-./0 1egistration of te company#• ,-230 4auncing of its own brands#

• ,-250 4isting in te Da!a 6toc! 'xcange )D6'+

• ,--70 6tarted export operation wit ActiveParmaceutical 8ngredients )AP8s+#

• ,--20 9irst parmaceutical company of tecountry acieving :ational 'xport (ropy )*old+:for ,--;%-5

8/19/2019 Presentation of Beximco Pharmaceuticals

5/22

 

'arning Per 6are

8/19/2019 Presentation of Beximco Pharmaceuticals

6/22

 

Mar!et price per sare

8/19/2019 Presentation of Beximco Pharmaceuticals

7/22

 

Price 'arning 1atio

8/19/2019 Presentation of Beximco Pharmaceuticals

8/22

 

'P6 and Dividend of

company

8/19/2019 Presentation of Beximco Pharmaceuticals

9/22

 

Dividend policy

Beximco parma follow

lo/ re)ular etra diidend

oliy

8/19/2019 Presentation of Beximco Pharmaceuticals

10/22

 

Capital structure

Combination of different sources ofcapital

8/19/2019 Presentation of Beximco Pharmaceuticals

11/22

 

Capital

'$uitycapital

Debtcapital

8/19/2019 Presentation of Beximco Pharmaceuticals

12/22

 

Distribution of e$uity

8/19/2019 Presentation of Beximco Pharmaceuticals

13/22

 

Distribution of debt

8/19/2019 Presentation of Beximco Pharmaceuticals

14/22

 

Degree of operating

leverage

6ows relationsip between sales &'B8( 

8/19/2019 Presentation of Beximco Pharmaceuticals

15/22

 

8/19/2019 Presentation of Beximco Pharmaceuticals

16/22

 

Degree of financial

leverage

6ows proportion of fixed financialobligation

8/19/2019 Presentation of Beximco Pharmaceuticals

17/22

 

8/19/2019 Presentation of Beximco Pharmaceuticals

18/22

 

Degree of total leverage

6ows relationsip between sales &'P6

8/19/2019 Presentation of Beximco Pharmaceuticals

19/22

 

8/19/2019 Presentation of Beximco Pharmaceuticals

20/22

 

8/19/2019 Presentation of Beximco Pharmaceuticals

21/22

 

D

8/19/2019 Presentation of Beximco Pharmaceuticals

22/22

 

After analy=ing it was found tat Beximcoparmaceuticals gave positive signal to tesareolders# Because tey ave

maintained teir dividend rate despitelower earnings and sales in 7>>.# Board ofdirectors as recommended ,>? stoc! and5? cas dividend% same as in prior year to

ensure better yield to ensure better yieldon te investment of valued sareolders#